68 - Challenging Consults in Mycology

Thursday, October 17, 2024

1:45 PM – 3:00 PM US PT

Location: Concourse 151

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

George Thompson, III, MD

Professor
Internal Medicine, Division of Infectious Diseases
University of California Davis Medical Center
Sacramento, CA, United States
Sarah Hammond, MD

Director of Hematology/Oncology Infectious Diseases
Infectious Diseases Division
Massachusetts General Hospital
Boston, MA, United States

Faculty(s)

Peter Pappas, MD

Professor of Medicine
Medicine
University of Alabama at Birmingham
Birmingham, AL, United States
Thomas Patterson, MD (he/him/his)

Professor and Chief, Infectious Diseases
University of Texas Health San Antonio
San Antonio, TX, United States

Disclosure(s):

George R. Thompson, MD, III: Astellas: Advisor/Consultant (); Cidara: Advisor/Consultant (), Grant/Research Support (); F2G: Advisor/Consultant (), Grant/Research Support (); Melinta: Advisor/Consultant (), Grant/Research Support (); Mundipharma: Advisor/Consultant (), Grant/Research Support (); Pfizer: Advisor/Consultant ()

Sarah P. Hammond, MD: Cidara Therapeutics Inc.: Grant/Research Support (Ongoing); F. Hoffmann-La Roche Ltd.: Advisor/Consultant (Terminated, November 8, 2023); F2G: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); GSK: Grant/Research Support (Ongoing); Melinta Therapuetics: Advisor/Consultant (Terminated, December 12, 2023); Pfizer, Inc.: Advisor/Consultant (Terminated, September 22, 2023); Scynexis Inc.: Grant/Research Support (Ongoing)

Peter G. Pappas, MD: F2G, Cidara, Scynexis, Mundipharma: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Thomas F. Patterson, MD: F2G: Grant/Research Support ()

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the epidemiology, diagnosis, and treatment of ocular fungal infections;
identify risk factors, diagnostic clues, and the approach to treatment of fungal endocarditis;
explain diagnostic and treatment options for fungal urinary tract infections.

Presentations:

1:45 PM – 2:10 PM US PT

Ocular Fungal Infections
Speaker: Thomas F. Patterson, MD (he/him/his) – University of Texas Health San Antonio
2:10 PM – 2:35 PM US PT

Fungal Endocarditis: Diagnosis and Management
Speaker: Peter G. Pappas, MD – University of Alabama at Birmingham
2:35 PM – 3:00 PM US PT

Fungal Disease of The Urinary System
Speaker: Sarah P. Hammond, MD – Massachusetts General Hospital